 PLYMOUTH MEETING, Pa. , July 19, 2022 PRNewswire -- Harmony Biosciences Holdings, Inc. Harmony or the Company Nasdaq: HRMY, a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that it will issue a press release on the Companys second quarter 2022 financial results on Tuesday, August 2, 2022. 